Short description
Immusoft is a biotechnology company that develops novel cell therapies for therapeutic protein delivery for rare diseases.
Description
Immusoft is a biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The core components of Immusoft’s Immune System Programming (ISP) technology was developed in the Baltimore Lab at the California Institute of Technology (Caltech) and exclusively licensed by Immusoft.
The technology instructs a patient’s cells to produce gene-encoded medicines (biologics). Cells that are reprogrammed using ISP become miniature drug factories that are expected to survive in patients for many years.
It was founded in 2009 and is headquartered in Seattle, Washington.
Total funding
$$121212
Sign in for full access
Location
Seattle, Washington, United States, North America
Founded on
January 1, 2009
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Investors
Nopepepe, Nopepepe, Blurry Noaccess, Noaccess, Noaccess, Uh Ohhhh, Absolutely Noaccess, Noaccess, Noaccess, Noway Youcantaccess, Noaccess, Cannot Access, Blurry Noaccess, No Way, Blurry Noaccess, Nopepepe, Noaccess, Noaccessforu, Cannot Access, Nopepepe, No Way, Noaccessforu, Cannot Access
Sign in for full access
Founders
Matthew Scholz